{"id":"https://openalex.org/W1968448551","doi":"https://doi.org/10.1248/cpb.58.38","title":"Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors","display_name":"Design and Synthesis of Peptidomimetic Factor VIIa Inhibitors","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W1968448551","doi":"https://doi.org/10.1248/cpb.58.38","mag":"1968448551","pmid":"https://pubmed.ncbi.nlm.nih.gov/20045964"},"language":"en","primary_location":{"id":"doi:10.1248/cpb.58.38","doi":"https://doi.org/10.1248/cpb.58.38","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.58.38","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/58/1/58_1_38/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/cpb/58/1/58_1_38/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041964655","display_name":"Takuya Shiraishi","orcid":"https://orcid.org/0000-0003-3543-1874","observed_orcids":["https://orcid.org/0000-0003-3543-1874","https://orcid.org/0009-0002-8637-3774"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuya Shiraishi","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]},{"raw_affiliation_string":"Fuji-Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007255434","display_name":"Shojiro Kadono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shojiro Kadono","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082108527","display_name":"Masayuki Haramura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Haramura","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hirofumi Kodama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hirofumi Kodama","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102389749","display_name":"Yoshiyuki Ono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Ono","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110935593","display_name":"Hitoshi Iikura","orcid":"https://orcid.org/0009-0007-0392-8663","observed_orcids":["https://orcid.org/0009-0007-0392-8663"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Iikura","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062937256","display_name":"Tohru Esaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tohru Esaki","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109077263","display_name":"Takaki Koga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takaki Koga","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013907733","display_name":"Kunihiro Hattori","orcid":"https://orcid.org/0009-0008-2707-1147","observed_orcids":["https://orcid.org/0009-0008-2707-1147"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kunihiro Hattori","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101486032","display_name":"Yoshiaki Watanabe","orcid":"https://orcid.org/0000-0002-6696-9602","observed_orcids":["https://orcid.org/0000-0002-6696-9602"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiaki Watanabe","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086300789","display_name":"Akihisa Sakamoto","orcid":"https://orcid.org/0009-0001-1685-8605","observed_orcids":["https://orcid.org/0009-0001-1685-8605"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akihisa Sakamoto","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054454647","display_name":"Kazutaka Yoshihashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazutaka Yoshihashi","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010392419","display_name":"Takehisa Kitazawa","orcid":"https://orcid.org/0000-0002-4958-7936","observed_orcids":["https://orcid.org/0000-0002-4958-7936"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takehisa Kitazawa","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067451452","display_name":"Keiko Esaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiko Esaki","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000011261","display_name":"Masateru Ohta","orcid":"https://orcid.org/0000-0002-6580-7185","observed_orcids":["https://orcid.org/0000-0002-6580-7185"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masateru Ohta","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071794274","display_name":"Haruhiko Sato","orcid":"https://orcid.org/0000-0002-1744-2388","observed_orcids":["https://orcid.org/0000-0002-1744-2388"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Haruhiko Sato","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041918162","display_name":"Toshiro Kozono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiro Kozono","raw_affiliation_strings":["Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Gotemba Research Laboratories, Chugai Pharmaceutical Co., Ltd","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405254473"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"58","issue":"1","first_page":"38","last_page":"44"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9063000082969666,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.021299999207258224,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viia-inhibitors","display_name":"factor VIIa inhibitors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/peptidomimetics","display_name":"peptidomimetics","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tissue-factor","display_name":"tissue factor","score":0.6990000009536743},{"id":"https://openalex.org/keywords/anticoagulants","display_name":"anticoagulants","score":0.7900000214576721},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.8550000190734863},{"id":"https://openalex.org/keywords/x-ray-crystal-structure","display_name":"X-ray crystal structure","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9368525743484497},{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.7889971733093262},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.7481037974357605},{"id":"https://openalex.org/C182220744","wikidata":"https://www.wikidata.org/wiki/Q7251226","display_name":"Proteases","level":3,"score":0.6922070980072021},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.630131185054779},{"id":"https://openalex.org/C2776414213","wikidata":"https://www.wikidata.org/wiki/Q183290","display_name":"Serine","level":3,"score":0.6180300712585449},{"id":"https://openalex.org/C2777807008","wikidata":"https://www.wikidata.org/wiki/Q87324999","display_name":"Serine protease","level":4,"score":0.6077343225479126},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.5382753014564514},{"id":"https://openalex.org/C186738567","wikidata":"https://www.wikidata.org/wiki/Q412841","display_name":"Tissue factor","level":3,"score":0.536332368850708},{"id":"https://openalex.org/C2779095896","wikidata":"https://www.wikidata.org/wiki/Q864401","display_name":"Bioisostere","level":4,"score":0.46796542406082153},{"id":"https://openalex.org/C192527728","wikidata":"https://www.wikidata.org/wiki/Q1465700","display_name":"Indole test","level":2,"score":0.46298256516456604},{"id":"https://openalex.org/C53105671","wikidata":"https://www.wikidata.org/wiki/Q14777816","display_name":"Rational design","level":2,"score":0.4567478895187378},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.4351062774658203},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.391110897064209},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.3089078664779663},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.2401627004146576},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.20689326524734497},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.20118212699890137},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1933385729789734},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.1038425862789154},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1023106575012207},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.08899611234664917},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.08437752723693848},{"id":"https://openalex.org/C2778382381","wikidata":"https://www.wikidata.org/wiki/Q179217","display_name":"Coagulation","level":2,"score":0.06701505184173584},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013925","descriptor_name":"Thromboplastin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013925","descriptor_name":"Thromboplastin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013925","descriptor_name":"Thromboplastin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015942","descriptor_name":"Factor VIIa","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015942","descriptor_name":"Factor VIIa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015942","descriptor_name":"Factor VIIa","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D032701","descriptor_name":"Biomimetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1248/cpb.58.38","doi":"https://doi.org/10.1248/cpb.58.38","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.58.38","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/58/1/58_1_38/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},{"id":"pmid:20045964","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20045964","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical & pharmaceutical bulletin","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1248/cpb.58.38","doi":"https://doi.org/10.1248/cpb.58.38","is_oa":true,"landing_page_url":"https://doi.org/10.1248/cpb.58.38","pdf_url":"https://www.jstage.jst.go.jp/article/cpb/58/1/58_1_38/_pdf","source":{"id":"https://openalex.org/S3861430","display_name":"Chemical and Pharmaceutical Bulletin","issn_l":"0009-2363","issn":["0009-2363","1347-5223"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313382","host_organization_name":"Pharmaceutical Society of Japan","host_organization_lineage":["https://openalex.org/P4310313382"],"host_organization_lineage_names":["Pharmaceutical Society of Japan"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical and Pharmaceutical Bulletin","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324720","display_name":"Soochow University","ror":"https://ror.org/05t8y2r12"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1968448551.pdf","grobid_xml":"https://content.openalex.org/works/W1968448551.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W256143173","https://openalex.org/W1518197977","https://openalex.org/W1539796472","https://openalex.org/W1868642721","https://openalex.org/W1985407614","https://openalex.org/W1994639049","https://openalex.org/W1994722792","https://openalex.org/W1997706326","https://openalex.org/W2003534922","https://openalex.org/W2011334005","https://openalex.org/W2019540469","https://openalex.org/W2023379404","https://openalex.org/W2025666242","https://openalex.org/W2038559423","https://openalex.org/W2045465178","https://openalex.org/W2046559823","https://openalex.org/W2063841163","https://openalex.org/W2068942883","https://openalex.org/W2079200660","https://openalex.org/W2087587905","https://openalex.org/W2104735281","https://openalex.org/W2109688131","https://openalex.org/W2112236275","https://openalex.org/W2116748983","https://openalex.org/W2134594019","https://openalex.org/W2169180060","https://openalex.org/W2172951791","https://openalex.org/W2238231990"],"related_works":["https://openalex.org/W1994639049","https://openalex.org/W1994722792","https://openalex.org/W2112236275","https://openalex.org/W1978520876","https://openalex.org/W2332146789","https://openalex.org/W4236974561","https://openalex.org/W2023379404","https://openalex.org/W2109688131","https://openalex.org/W2063841163","https://openalex.org/W2029650088"],"abstract_inverted_index":{"Selective":[0],"factor":[1,3,40],"VIIa-tissue":[2],"complex":[4],"(FVIIa/TF)":[5],"inhibition":[6,56],"is":[7],"regarded":[8],"as":[9],"a":[10,23],"promising":[11],"target":[12],"for":[13,58],"developing":[14],"new":[15],"anticoagulant":[16],"drugs.":[17],"In":[18],"previous":[19],"reports,":[20],"we":[21,66],"described":[22],"S3":[24],"subsite":[25],"found":[26],"in":[27],"the":[28,44,51,55,76,102],"X-ray":[29,45,104],"crystal":[30,46],"structure":[31,47,105],"of":[32,53,75,79],"compound":[33,80,84,97,109],"2":[34],"that":[35,108],"bound":[36],"to":[37,94],"FVIIa/soluble":[38],"tissue":[39],"(sTF).":[41],"Based":[42],"on":[43],"information":[48],"and":[49,60,120],"with":[50,117],"aim":[52],"improving":[54],"activity":[57],"FVIIa/TF":[59],"selectivity":[61,88,112],"against":[62,89],"other":[63,90],"serine":[64,91],"proteases,":[65],"synthesized":[67],"derivatives":[68],"by":[69,113],"introducing":[70],"substituents":[71],"at":[72],"position":[73],"5":[74],"indole":[77],"ring":[78],"2.":[81],"Among":[82],"them,":[83],"16":[85,98,110],"showed":[86],"high":[87],"proteases.":[92],"Contrary":[93],"our":[95],"expectations,":[96],"did":[99],"not":[100],"occupy":[101],"S3-subsite;":[103],"analysis":[106],"revealed":[107],"improved":[111],"forming":[114],"hydrogen":[115],"bonds":[116],"Gln217,":[118],"Thr99":[119],"Asn100.":[121]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}